HIV therapeutics.
作者信息
Richman D D
机构信息
San Diego Veterans Affairs Medical Center, La Jolla, California 92092-0679, USA.
出版信息
Science. 1996 Jun 28;272(5270):1886-8. doi: 10.1126/science.272.5270.1886.
PMID:8658159
Abstract
摘要
相似文献
1
HIV therapeutics.艾滋病病毒治疗学
Science. 1996 Jun 28;272(5270):1886-8. doi: 10.1126/science.272.5270.1886.
2
Therapeutic interventions in primary HIV infection.原发性HIV感染的治疗干预措施。
J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 1:S69-76.
3
Eradicating HIV from a patient: not just a dream?从患者体内根除艾滋病毒：这只是个梦吗？
Science. 1996 Jun 28;272(5270):1884. doi: 10.1126/science.272.5270.1884.
4
High turnover of HIV in blood revealed by new studies.新研究揭示血液中HIV周转迅速。
Science. 1995 Jan 13;267(5195):179. doi: 10.1126/science.7809623.
5
Viral dynamics of HIV: implications for drug development and therapeutic strategies.HIV的病毒动力学：对药物研发和治疗策略的启示
Ann Intern Med. 1996 Jun 1;124(11):984-94. doi: 10.7326/0003-4819-124-11-199606010-00006.
6
[New biological monitoring of HIV infection].[艾滋病病毒感染的新生物监测]
Rev Prat. 1998 Mar 1;48(5):472-7.
7
Viral dynamics in human immunodeficiency virus type 1 infection.1型人类免疫缺陷病毒感染中的病毒动力学
Nature. 1995 Jan 12;373(6510):117-22. doi: 10.1038/373117a0.
8
Viral counts count in HIV infection.病毒载量在HIV感染中很重要。
Science. 1996 May 24;272(5265):1124-5. doi: 10.1126/science.272.5265.1124.
9
Can HIV infection be eradicated through use of potent antiviral agents?通过使用强效抗病毒药物，能否根除 HIV 感染？
Curr Opin Infect Dis. 2010 Dec;23(6):628-32. doi: 10.1097/QCO.0b013e32833ff1d0.
10
Early treatment of HIV infection.
N Engl J Med. 1995 Dec 28;333(26):1782; author reply 1783.
引用本文的文献
1
A Report on Finding a New Peptide Aldehyde from Cyanobacterium Bahar M by LC-MS and Marfey's Analysis.通过液相色谱-质谱联用（LC-MS）和马尔费伊分析法从蓝藻巴哈尔M中寻找新型肽醛的报告。
Iran J Biotechnol. 2019 Apr 20;17(2):e1853. doi: 10.21859/ijb.1853. eCollection 2019 Apr.
2
Designing and developing suppository formulations for anti-HIV drug delivery.设计和开发用于抗艾滋病毒药物递送的栓剂制剂。
Ther Deliv. 2017 Aug;8(9):805-817. doi: 10.4155/tde-2017-0056.
3
Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.用于有效透皮递送HIV抑制剂的当前及新出现的制剂策略。
Ther Deliv. 2015 Feb;6(2):217-29. doi: 10.4155/tde.14.110.
4
In vitro and ex vivo evaluations on transdermal delivery of the HIV inhibitor IQP-0410.HIV抑制剂IQP-0410经皮给药的体外和离体评价
PLoS One. 2013 Sep 18;8(9):e75306. doi: 10.1371/journal.pone.0075306. eCollection 2013.
5
Development of topical microbicides to prevent the sexual transmission of HIV.发展局部抗微生物制剂以预防艾滋病毒的性传播。
Antiviral Res. 2010 Jan;85(1):142-58. doi: 10.1016/j.antiviral.2009.10.013. Epub 2009 Oct 27.
6
Comparative evaluation of the inhibitory activities of a series of pyrimidinedione congeners that inhibit human immunodeficiency virus types 1 and 2.一系列抑制1型和2型人类免疫缺陷病毒的嘧啶二酮同系物抑制活性的比较评估
Antimicrob Agents Chemother. 2008 Jan;52(1):225-36. doi: 10.1128/AAC.00972-07. Epub 2007 Oct 29.
7
Modulation of human immunodeficiency virus (HIV)-specific immune response by using efavirenz, nelfinavir, and stavudine in a rescue therapy regimen for HIV-infected, drug-experienced patients.在针对感染人类免疫缺陷病毒（HIV）且有药物治疗史的患者的挽救治疗方案中，使用依非韦伦、奈非那韦和司他夫定对HIV特异性免疫反应进行调节。
Clin Diagn Lab Immunol. 2002 Sep;9(5):1114-8. doi: 10.1128/cdli.9.5.1114-1118.2002.
8
HIV in the CNS: pathogenic relationships to systemic HIV disease and other CNS diseases.中枢神经系统中的人类免疫缺陷病毒：与全身性人类免疫缺陷病毒疾病及其他中枢神经系统疾病的致病关系。
J Neurovirol. 2001 Apr;7(2):85-96. doi: 10.1080/13550280152058744.
9
Efficacy of antiretroviral agents against murine replication-competent retrovirus infection in human cells.抗逆转录病毒药物对人类细胞中具有复制能力的鼠逆转录病毒感染的疗效。
J Virol. 1999 Oct;73(10):8813-6. doi: 10.1128/JVI.73.10.8813-8816.1999.
10
Irreversible inhibition of human immunodeficiency virus type 1 integrase by dicaffeoylquinic acids.二咖啡酰奎宁酸对1型人类免疫缺陷病毒整合酶的不可逆抑制作用。
J Virol. 1999 Apr;73(4):3309-16. doi: 10.1128/JVI.73.4.3309-3316.1999.
Zotero 插件